NFA
KIN

Nationwide Fund Advisors’s Kindred Biosciences, Inc. KIN Stock Holding History

Nationwide Fund Advisors’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,629
Closed -$91K – 2555
2017
Q3 		$91K Hold
11,629
– – ﹤0.01% 2938
2017
Q2 		$100K Buy
+11,629
New +$83.4K ﹤0.01% 2899
2017
Q1 		– Sell
-10,700
Closed -$45K – 3223
2016
Q4 		$45K Buy
10,700
+2,100
+24% +$10.2K ﹤0.01% 3021
2016
Q3 		$43K Hold
8,600
– – ﹤0.01% 3067
2016
Q2 		$30K Hold
8,600
– – ﹤0.01% 3125
2016
Q1 		$30K Buy
8,600
+600
+8% +$2.12K ﹤0.01% 3062
2015
Q4 		$27K Buy
8,000
+3,100
+63% +$14.4K ﹤0.01% 3052
2015
Q3 		$25K Buy
4,900
+700
+17% +$4.32K ﹤0.01% 3108
2015
Q2 		$29K Sell
4,200
-7,572
-64% -$53.7K ﹤0.01% 3140
2015
Q1 		$84K Buy
11,772
+1,452
+14% +$10K ﹤0.01% 3003
2014
Q4 		$77K Buy
10,320
+2,000
+24% +$17K ﹤0.01% 2969
2014
Q3 		$77K Buy
8,320
+13
+0.2% +$176 ﹤0.01% 3049
2014
Q2 		$155K Buy
8,307
+5,659
+214% +$96.1K ﹤0.01% 2864
2014
Q1 		$49K Buy
+2,648
New +$50.5K ﹤0.01% 2856

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PVAM
Pacific View Asset Management San Francisco, California $20.8M AUM 20.08% 1-Year Est. Return

Nationwide Fund Advisors's KIN Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Kindred Biosciences, Inc. (KIN) in Q4 2017, closing a stake of 11,629 shares — an estimated $91K sold.

Nationwide Fund Advisors first reported a position in KIN in Q1 2014 and held it in 14 quarters. The position peaked at $155K in Q2 2014. 61 funds tracked by Wall St. Rank hold KIN as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Kindred Biosciences, Inc. position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 11,629 Kindred Biosciences, Inc. shares in Q4 2017, an estimated $91K.
  • Nationwide Fund Advisors first reported a position in Kindred Biosciences, Inc. in Q1 2014 and held it in 14 quarters.
  • Nationwide Fund Advisors's Kindred Biosciences, Inc. position peaked at $155K in Q2 2014.
  • 61 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.